These press releases were issued in Canada and are intended as a resource for Canadian journalists.

Information provided within the individual releases was accurate at the time of distribution, and Takeda Canada, Inc. assumes no responsibility for updating the archived information to reflect new developments.

For more information on the news releases or to speak with Corporate Communications call 1-888-825-3321.

Sept 8th, 2011 - ALBERTA GOVERNMENT PROVIDES ULORIC® COVERAGE BY SPECIAL AUTHORIZATION FOR PEOPLE SUFFERING WITH GOUT

Sept 8th, 2011 - NEWFOUNDLAND AND LABRADOR GOVERNMENT PROVIDES ULORIC® COVERAGE BY SPECIAL AUTHORIZATION FOR PEOPLE SUFFERING WITH GOUT

Sept 8th, 2011 - SASKATCHEWAN GOVERNMENT PROVIDES ULORIC® REIMBURSEMENT FOR PEOPLE SUFFERING WITH GOUT

June 7th, 2011 - QUEBEC GOVERNMENT PROVIDES ULORIC® REIMBURSEMENT FOR PEOPLE SUFFERING WITH GOUT

June 3rd, 2011 - QUEBEC PROVIDES GERD SUFFERERS WITH MUCH NEEDED RELIEF

October 21st, 2010 - FOR THE FIRST TIME IN DECADES PATIENTS LIVING WITH GOUT HAVE NEW TREATMENT OPTION AVAILABLE

September 22, 2010 - PATIENTS LIVING WITH GERD NOW HAVE A NEW TREATMENT OPTION FOR IMPROVED AND SUSTAINED SYMPTOM RELIEF

September 13, 2010 - Takeda Canada, Inc. Names New General Manager

September 2nd, 2010 - Orexigen® Therapeutics and Takeda Enter into Partnership to Commercialize Contrave® in North America

April 28th, 2010 - Takeda Canada Celebrates First Anniversary

August 21st, 2009 - Takeda Reacquires Rights to Leading Diabetes Drug in Canada

March 26th, 2009 - Takeda Establishes Presence in Canada